🇺🇸 FDA
Pipeline program

commercially available saline solution for infusion, Amlenetug 53 mg/ml solution for infusion

20432A

Phase 3 small_molecule active

Quick answer

commercially available saline solution for infusion, Amlenetug 53 mg/ml solution for infusion for Multiple System Atrophy is a Phase 3 program (small_molecule) at H. Lundbeck A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
H. Lundbeck A/S
Indication
Multiple System Atrophy
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials